To evaluate the clinical prognostic significance of DSN1 across various cancer types, we conducted a comprehensive analysis of its association with overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), and progression-free interval (PFI) using data from 33 cancer types in the TCGA database. The gene discussed is DSN1; the disease is cancer.